NYSE
$21.97▲ 0.09%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $853.1MShares out 38.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 10.5After-hours26.10.06 05:594Ownership#●●●
Alto Neuroscience, Inc.
Insider Smith Nicholas Conrad filed a Form 4 on October 5, 2026, reporting a change in beneficial ownership of securities for Alto Neuroscience, Inc. effective as of October 2, 2026. This filing serves as a standard disclosure of insider transaction activity.…more
$21.97+0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.2Overnight26.10.02 10:334Ownership
Alto Neuroscience, Inc.
Insider Smith Nicholas Conrad reported a change in beneficial ownership of Alto Neuroscience, Inc. securities as of September 29, 2026. This filing serves as the official disclosure of the insider's equity transaction to the SEC.…more
$21.97+0.09%vs prev closeView filingShare - 9.29After-hours26.09.30 05:23144Ownership
Alto Neuroscience, Inc.
Alto Neuroscience insider Smith Nicholas Conrad has filed an SEC Form 144 to report a proposed sale of company shares. This is a standard filing disclosing an insider's plan to dispose of their holdings.…more
$21.97+0.09%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.27After-hours26.08.28 05:09#●●●#●●●
Alto Neuroscience Promotes Nick Smith to President and CFO
Alto Neuroscience has promoted Nick Smith to the roles of president and chief financial officer, effective August 26. This leadership change marks a strategic update for the clinical-stage biopharmaceutical company.…more
$21.97+0.09%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga